Public COA audit

Triple Agonist

Audited July 28, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
92
Confidence
88%
Panels
5/7
Purity (printed)
99.94%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CR-3XAG20-2605-2
Identity method
HPLC-RTM (retention time matching)
Sample date
2026-05-27
Issue date
2026-06-01

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

5 of 7 present · 5 passed · 0 failed · 0 reported · 2 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.94%

  • Heavy metals

    Tested · passed

    Lead, arsenic, cadmium, mercury, or similar limits.

    All Not Detected (As, Cd, Cr, Hg, Pb)

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    NMT 0.05 EU/mL

  • Sterility

    Tested · passed

    Sterility testing where applicable.

    No Growth

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    99.94% purity by HPLC with conformity testing across 3 samples (mean 99.84%, std dev 0.119%). This is normal for research-grade peptides.

  • Identity confirmed

    Triple Agonist confirmed by HPLC retention time matching with reference standard.

  • Batch information complete

    Lot number CR-3XAG20-2605-2, COA number COA-2026-VQSK1R, Accession ACC-2026-3355.

  • Dates consistent

    Sample received 05/27/2026, analyzed 06/01/2026, issued 06/01/2026. All dates are logical and on or before 2026-07-28.

  • Lab information present

    ILS Laboratories, San Diego CA, ISO/IEC 17025 accredited, with verification URL and access code provided.

  • Comprehensive testing

    Includes purity, identity, heavy metals, endotoxin, sterility, and fentanyl screening. Missing only microbial culture and residual solvents.

  • Fentanyl screening included

    Immunoassay fentanyl screen (50 ng/mL cutoff) shows Not Detected, which is a positive safety feature.

  • Professional presentation

    Well-formatted 2-page COA with chromatogram, conformity testing data, methodology notes, and signature.

  • Lab verification recommended

    While the COA appears legitimate, independent verification via the provided URL (portal.ils-lab.com/verify/aHTY0Yz5qVSTKfz8) and access code (UAXLYPLJ) is recommended to confirm authenticity.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.